Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kaiser

Showing results (371-380 of 554) with videos related to

Pageof 56
Sort By:
The New England Journal of Medicine|October 6, 2006
Ranibizumab for neovascular age-related macular degenerationPhilip J Rosenfeld, David M Brown, Jeffrey S Heier, et al.
The New England Journal of Medicine|October 6, 2006
Ranibizumab versus verteporfin for neovascular age-related macular degenerationDavid M Brown, Peter K Kaiser, Mark Michels, et al.
Retina (Philadelphia, Pa.)|July 25, 2013
Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysisPeter Stalmans, Jay S Duker, Peter K Kaiser, et al.
Ophthalmology. Retina|June 30, 2020
Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective TrialsHannah J Yu, Peter K Kaiser, Deneva Zamora, et al.
Neurology|February 1, 1986
Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosisM H Brooke, J M Florence, S L Heller, et al.
The British Journal of Ophthalmology|December 21, 2013
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndromeRishi P Singh, Ang Li, Rumneek Bedi, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 28, 2016
The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular EdemaDarius M Moshfeghi, Peter K Kaiser, Stephan Michels, et al.
American Journal of Ophthalmology|April 17, 2007
Multifocal posterior necrotizing retinitisRon Margolis, Oswaldo Ferreira Moura Brasil, Careen Y Lowder, et al.
American Journal of Ophthalmology|October 24, 2007
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR resultsPeter K Kaiser, David M Brown, Kang Zhang, et al.
JAMA Ophthalmology|July 31, 2015
Determination of feasibility and utility of microscope-integrated optical coherence tomography during ophthalmic surgery: the DISCOVER Study RESCAN ResultsJustis P Ehlers, Jeff Goshe, William J Dupps, et al.
Pageof 56

Showing results (371-380 of 554) with videos related to

Sort By:
Pageof 56
The New England Journal of Medicine|October 6, 2006
Ranibizumab for neovascular age-related macular degenerationPhilip J Rosenfeld, David M Brown, Jeffrey S Heier, et al.
The New England Journal of Medicine|October 6, 2006
Ranibizumab versus verteporfin for neovascular age-related macular degenerationDavid M Brown, Peter K Kaiser, Mark Michels, et al.
Retina (Philadelphia, Pa.)|July 25, 2013
Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysisPeter Stalmans, Jay S Duker, Peter K Kaiser, et al.
Ophthalmology. Retina|June 30, 2020
Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective TrialsHannah J Yu, Peter K Kaiser, Deneva Zamora, et al.
Neurology|February 1, 1986
Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosisM H Brooke, J M Florence, S L Heller, et al.
The British Journal of Ophthalmology|December 21, 2013
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndromeRishi P Singh, Ang Li, Rumneek Bedi, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 28, 2016
The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular EdemaDarius M Moshfeghi, Peter K Kaiser, Stephan Michels, et al.
American Journal of Ophthalmology|April 17, 2007
Multifocal posterior necrotizing retinitisRon Margolis, Oswaldo Ferreira Moura Brasil, Careen Y Lowder, et al.
American Journal of Ophthalmology|October 24, 2007
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR resultsPeter K Kaiser, David M Brown, Kang Zhang, et al.
JAMA Ophthalmology|July 31, 2015
Determination of feasibility and utility of microscope-integrated optical coherence tomography during ophthalmic surgery: the DISCOVER Study RESCAN ResultsJustis P Ehlers, Jeff Goshe, William J Dupps, et al.
Pageof 56